Edesa Biotech, Inc.
Q4 2023 13F Holders
Symbol
EDSA
CUSIP
27966L306
Type
Equity
Class
COM NEW
Num filings
21
Total reported value, excl. options
$507 k
Compare 2023 Q4 to
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type